KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 156 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $72,357,000 | -19.3% | 965,015 | -18.9% | 0.02% | -9.5% |
| Q2 2015 | $89,623,000 | +63.0% | 1,190,053 | +8.5% | 0.02% | +61.5% |
| Q1 2015 | $54,987,000 | +60.1% | 1,096,458 | +10.7% | 0.01% | +62.5% |
| Q4 2014 | $34,344,000 | +19.0% | 990,320 | +12.4% | 0.01% | 0.0% |
| Q3 2014 | $28,858,000 | -11.9% | 880,896 | +3.1% | 0.01% | -11.1% |
| Q2 2014 | $32,770,000 | +16.9% | 854,064 | +21.1% | 0.01% | +12.5% |
| Q1 2014 | $28,036,000 | +32.8% | 705,140 | +24.8% | 0.01% | +33.3% |
| Q4 2013 | $21,109,000 | +61.2% | 565,171 | +96.8% | 0.01% | +50.0% |
| Q3 2013 | $13,092,000 | +90.7% | 287,184 | +13.1% | 0.00% | +33.3% |
| Q2 2013 | $6,867,000 | – | 253,879 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
| Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
| AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
| SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
| Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
| PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
| Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
| HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
| Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |